Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016.
Man Fung TsoiMan Ho ChungBernard Man Yung CheungChak Sing LauTommy Tsang CheungPublished in: Arthritis research & therapy (2020)
Population ageing as well as other risk factors contributed to an increase in the incidence and prevalence of gout in Hong Kong. In 2016, the crude prevalence of gout in Hong Kong was comparable to that in many western countries. However, only one in four patients with gout in Hong Kong was prescribed ULT.